ArticleInternational journal of molecular sciences2025

Combined XPO1 Inhibition and Parthenolide Treatment Can Be Efficacious in Treating Triple-Negative Breast Cancer.

Amy L Paulson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.